. Similarly, the nucleocapsid protein of canine distemper virus (CDV) is recognized in a TAP-independent fashion. In addition, a recombinant MV expressing bacterial β-galactosidase protein is able to introduce the recombinant antigen into the TAPindependent pathway whereas a vaccinia virus expressing β-galactosidase is not. These data and a report about TAP-independent recognition of parainfluenza virus type 1 suggest that members of the Paramyxoviridae family regularly introduce viral proteins into the TAP-independent antigenprocessing pathway.
Introduction
Cytotoxic T cells (CTL) play an important role in combating viral diseases. After infection viral proteins are processed in the cytosol by the ubiquitin proteasome complex for presentation to CD8 + T cells. The peptide epitopes generated are transported into the endoplasmic reticulum (ER) by the heterodimer transporters of antigen presentation (TAP 1 and 2) and loaded onto MHC class I molecules, which traverse the Golgi to the cell membrane. Antigen presentation via this endogenous processing pathway can be blocked by brefeldin A. Alternatively, exogenously added viral proteins or inactivated viruses can be presented via the exogenous chloroquinesensitive pathway to MHC class I-restricted T cells (Bachmann et al., 1995 ; Jondal et al., 1996) . Recent evidence suggests that this alternative pathway might occur in vivo more often than previously recognized (Sigal et al., 1999) . A well-studied example of presentation via the exogenous pathway is that of hepatitis B virus (HBV) core antigen by the L d molecule in TAP-deficient cells. Presumably empty L d molecules recycle from the cell surface through the endolysosomal compartment where they are loaded with the appropriate peptide (Schirmbeck et al., 1995 (Schirmbeck et al., , 1997 . Infection of the TAP-deficient cell line 174iCEM.T2 with Sendai virus (parainfluenza virus type 1, family Paramyxoviridae) leads to presentation via the K b molecule (Zhou et al., 1993) . Recognition by CTL cannot be abrogated by brefeldin A (Zhou et al., 1993) and after heat-inactivation the virus is still able to sensitize TAP-deficient cells to CTL lysis (Liu et al., 1995) . This indicates that processing occurs in endolysosomes. Recently, Gromme et al. (1999) reported that HLA-B2705-restricted CTL recognize the measles virus (MV) fusion protein in a TAP-independent manner. In contrast, HLA-A2-restricted CTL rely on TAP for recognition of epitopes derived from the haemagglutinin (MV-H) and nucleocapsid (MV-N) proteins of MV (Nanan et al., 1995) . Here we report that the N proteins of MV and canine distemper virus (CDV), members of the Paramyxoviridae family, are recognized in a TAP-independent, chloroquine-sensitive manner. Antigen presentation is restricted by the mouse L d molecule and virus replication is required for presentation via the exogenous antigen-processing pathway. Using standard MV and a recombinant MV expressing the bacterial protein β-galactosidase (MV-lacZ) both the N protein and the β-galactosidase are recognized by CD8 + T cells in a TAP-independent manner. In contrast, expression of these proteins by recombinant vaccinia virus did not result in TAPindependent recognition by CTL.
Methods
Mice. BALB\c mice were bought from Harlan Winkelmann (Borchem, Germany) and were specific pathogen free (specification according to the company). The animals were checked for pathogens by quarterly serological examination. Animals were kept in a barrier system with light negative pressure (100 mPa), a 12 h day (artificial light), and were fed and watered ad libitum. The room temperature (22 mCp2 mC) and the humidity (55 %p5 %) were regulated by air conditioning. Mice used were 6-18 weeks old.
Infection of mice.
For generation of CTL, BALB\c mice were infected intraperitoneally (i.p.) with 8i10' p.f.u. MV (Edmonston strain) or 2i10' p.f.u. of the vaccinia virus recombinant expressing β-galactosidase (vv52-59\β-gal).
Preparation of UV-inactivated MV. MV was grown on Vero cells according to standard procedures (Niewiesk et al., 1993) and UVinactivated with a UV handset (wavelength 254 nm) for 10 min ; 100 µg UV-inactivated virus did not yield infectious virus on Vero cells. (Beauverger et al., 1993) ] and TPHPARIGL [β-galactosidase, aa 876-884, L d -restricted (Gavin et al., 1993) ] were synthesized and purified ( 90 %) by Jerini Biotools, Berlin, Germany.
Generation and culture of CTL. For generation of CD8 + T cells, spleen cells from BALB\c mice were irradiated (30 Gy) and infected with MV (Edmonston strain) at an m.o.i. of 1 or incubated with epitope peptide (50 µg\10( cells) at 37 mC for 2 h ; 3i10' infected stimulators were cultivated in an upright 50 ml flask containing 15 ml RPMI-10 % FCS and 1n5i10( spleen cells from infected animals. After 7 days, living cells were separated on a Percoll gradient (1n083 g\ml) and plated at a density of 10'cells\ml in tissue culture plates. For restimulation spleen cells (10' cells\ml) infected with virus or incubated with peptide (see above) and 2 % rat spleen Concanavalin A supernatant (ConA-S) were added. T cells were tested for their cytolytic activity 5 days after restimulation. Elispot for interferon-γ-producing CTL. Elispot assays for IFN-γ were performed with slight modifications according to established protocols (Fujihashi et al., 1993 ; Sarawar & Doherty, 1994) . Briefly, 96-well nitrocellulose-based microtitre plates (Milititre HA ; Milipore) were coated overnight at 4 mC with anti-IFN-γ MAb clone 1-D1-K at a concentration of 15 µg\ml in PBS (Ho$ lzel Diagnostik, Ko$ ln, Germany). After washing with PBS, 1i10& lymphocytes were added to the wells with uninfected or MV-infected APC and incubated for 24 h at 37 mC. After removal of the cells biotinylated anti-IFN-γ MAb clone 7-B6-1 (Ho$ lzel Diagnostik) was added, and incubated overnight at 4 mC. Plates were washed with PBS and streptavidin-conjugated alkaline phosphatase (Ho$ lzel Diagnostik) was added, followed by 2 h incubation at room temperature. Spots representing individual IFN-γ-secreting cells were visualized using the Bio-Rad alkaline phosphatase conjugate substrate kit. Wells were photographed with a Wild Fotomikroskop M400 camera (Wild, Heebrugg, Germany). Spots were counted after slide projection. All assays were performed in triplicate.
Cytotoxicity

Vaccinia virus recombinants.
Recombinant vaccinia viruses expressing epitope aa 281-289 on the MV-N protein together with a signal sequence for targeting the epitope into the ER, β-galactosidase (vv52-59\β-gal) and MV-N protein have been described previously (Neumeister & Niewiesk, 1998) .
Construction and rescue of recombinant MV-lacZ virus.
In order to generate a recombinant MV expressing β-galactosidase, the green fluorescent protein (GFP) cassette cloned into the additional transcription unit (ATU) between the P and M gene of p(j)MPlrGFPV (Singh et al., 1999) was replaced by a lacZ expression cassette. P(j)MPlrGFPV was cut with SnaBI and BssHII and the larger cleavage product containing the MV antigenome and the plasmid backbone was treated with Klenow polymerase, and subsequently dephosphorylated using calf intestinal alkaline phosphatase (CIAP) according to published protocols. The lacZ gene was isolated from plasmid pCMV lacZ (Kupfer et al., 1994) by cleaving with PstI and PpuMI. After treatment with Klenow polymerase, the lacZ fragment was blunt-ligated into the MV vector backbone. Transformed bacteria were then screened by colony hybridization. Correct orientation of the insert as well as proper bluntend ligation were verified by sequencing. MV shares a particular property with other Paramyxovirinae. For efficient replication and to generate functional infectious particles, the genome length has to be a multiple of six. The remaining MV antigenome after cleavage of p(j)MPlrGFPV retained 15 998 nt, and the isolated lacZ transcription unit had a size of 3196 nt which after ligation with the MV backbone gave rise to the 19 194 nt MV-lacZ antigenome, which is a multiple of six. Measles virus presentation Measles virus presentation 4D system. Images of both labels were obtained simultaneously with an argon-krypton laser as the source of light and were superimposed. Crosstalk between the two fluorochromes was excluded by taking control images of both labellings separately.
Confocal laser microscopy. Infected and uninfected T2-L
Results
Recognition of TAP-negative T2-L d cells infected with MV depends on virus replication
It has been shown previously that MV fusion protein can be presented in a TAP-independent fashion via the HLA-B2705 molecule (Gromme et al., 1999) . We tested whether MV-derived epitope peptides are presented to mouse CTL in human and mouse cells with or without TAP after infection. L d -restricted CTL specific for aa 281-289 of the MV-N protein (Fig.  1 a) . The main difference between mouse and human cell lines is that in the human cell lines C1R-L d and T2-L d (lacking the TAP molecules) MV replicates after infection whereas in the mouse cell lines P815 and RMA-S-L d (lacking TAP 1) MV replicates abortively. Therefore, these data indicated that MV-N is presented in the absence of TAP via the exogenous antigen-processing pathway, but only in cells replicating the virus. In mouse cells with fully functional TAP proteins MV infection for 4-6 h is able to sensitize target cells for lysis via L d (Niewiesk et al., 1993) . The MV glycoproteins mediate uptake of the viral core into the cytoplasm and the N protein is subsequently processed via the endogenous pathway. In contrast, infection of TAP-deficient cells with an m.o.i. of 10 for 16 h did not render target cells susceptible whereas infection with a low m.o.i. of 0n1 for 48 h, allowing efficient replication, induced good recognition by CTL (Fig. 1 b) . In addition, incubation of T2-L d cells with UV-inactivated MV for 16 h did not lead to recognition by CTL (Fig. 1 b) . All these data indicate that virus replication is a prerequisite for MV recognition via the L d molecule in TAP-deficient cells.
L d -restricted, TAP-independent CTL recognition of MV-N protein is inhibited by chloroquine
As MV-N was presented by TAP-deficient T2-L d cells, it was assumed that the exogenous processing and presentation pathway was used. To confirm this hypothesis, T2-L d cells were incubated with chloroquine, which increases the pH of endosomes and thereby interferes with antigen processing via the exogenous pathway. Recognition of MV-infected T2-L d cells by MV-N-specific CTL was strongly reduced (Fig. 2) .
MV-N is present in the endosomal/lysosomal compartment
Since presentation of MV-N can be inhibited by chloroquine, MV-N should be physically present in the endo- lysosomal compartment. In addition, previous research has provided indirect evidence that L d molecules recycle through the endosome infection and some colocalized with LAMP-1 (Fig. 3) . Interestingly, in infected C1R-L d cells the extent of colocalization was reduced as compared to T2-L d cells (data not shown). When MV-N was expressed via vaccinia virus no colocalization could be detected (Fig. 3) . After infection with MV, the matrix protein was also shown to colocalize with LAMP-1 whereas the haemagglutinin protein did not (data not shown).
Expression of the MV-N epitope 281/289 via MV or CDV but not vaccinia virus leads to recognition by CTL
After expression of MV-N via a recombinant vaccinia virus (vvN), MV-N was not present in the endolysosomal compartment indicating that it would not be recognized by CTL. In agreement with the data obtained by confocal laser scanning microscopy, infection of T2-L d cells with vvN did not lead to recognition by CTL (Fig. 4) . To exclude the possibility that vaccinia virus infection interfered with presentation of the 281\289 epitope, we tested recognition of a recombinant vaccinia virus expressing the epitope with a signal sequence for targeting the epitope into the ER in a TAP-independent manner (vvL281-289). vvL281-289 was efficiently recognized (Fig. 4) . This indicates that vaccinia virus per se does not inhibit CTL recognition in T2-L d cells.
The 280\289 epitope derived from MV-N is present as a cross-reactive epitope in the N protein of CDV (Beauverger et al., 1993) . CDV replicated in T2-L d cells although synthesis of N was not as efficient as after either vvN or MV infection (data not shown). Infection of T2-L d cells with CDV led to their recognition by CTL. This indicated that the two closely related viruses, MV and CDV, share features of assembly and budding which are important for the import of viral protein into the endolysosomal compartment.
β-Galactosidase expression by recombinant MV leads to TAP-independent recognition by CTL
As MV was able to introduce both MV-N and MV-M into the endolysosomal compartment we investigated whether a bacterial protein like β-galactosidase could be introduced into the TAP-independent processing pathway by MV. To this end we produced a recombinant MV expressing β-galactosidase (MV-lacZ). This protein is recognized by L d -restricted CTL via the epitope aa 876-884 (Rammensee et al., 1989) . The stable expression of β-galactosidase over 15 passages was followed by Western blot analysis (Fig. 5 a) . Recognition of MV-lacZ by L d -restricted β-galactosidase CTL was compared to recognition of the vaccinia virus recombinant vv52-59\β-gal which has been described previously (Neumeister & Niewiesk, 1998) . This recombinant produces in addition to a K k -restricted epitope high levels of β-galactosidase and is recognized in P815 cells by CTL (data not shown). T2-L d cells infected with MV-lacZ were recognized by CTL specific for epitope 876-884 (Fig. 5 b) . In contrast, T2-L d cells infected with vv52-59\β-gal were not recognized by CTL.
Recognition of MV is dependent on the MHC class I molecule
TAP-independent presentation of proteins seems to vary according to peptide and MHC class I molecule ; in contrast to L d HLA-A2-restricted CTL do not lyse MV-infected T2 cells (Nanan et al., 1995) although they lyse the parental 174iCEM.T1 cells with intact TAP. However, lytic activity is the last step in the CTL activation cascade. To determine whether an early activation of HLA-A2-restricted CTL is due to presentation of MV-N, we used an IFN-γ Elispot system. Peripheral blood lymphocytes (PBL) from an HLA-A2-positive individual with a proven MV-specific CTL response were incubated for 24 h with HLA-A2-matched B-LCL or T2-L d cells (with or without MV infection). As the PBL contain Epstein-Barr virus (EBV), EBV-specific CTL secreting IFN-γ were seen after coculture of PBL and B-LCL in the absence of MV infection. After infection with MV, the number of spots increased indicating an additional MV response (Fig. 6) . In contrast, neither uninfected nor MV-infected T2-L d cells stimulated IFN-γ secretion by HLA-A2-restricted CTL. This indicates that even early activation of CTL does not occur via HLA-A2 and that only L d presents epitope peptides from MV-N in TAP-deficient cells.
Discussion
In vitro, a variety of viral proteins can be presented to CD8 + T cells in a TAP-independent, chloroquine-sensitive manner (summarized in Jondal et al., 1996) . In vivo, it has been suggested that professional antigen-presenting cells usually acquire antigen by this route during an infection (Sigal et al., 1999) . As a prerequisite for TAP-independent, chloroquinesensitive antigen presentation both the MHC I molecule and the viral antigen have to be transported into the endolysosomal compartment. There is evidence that MHC class I molecules recycle from the cell surface and references therein ; Gromme et al. (1999) ] to the endolysosome where they are mostly degraded. This may explain why a high level of HLA-B27 molecules is necessary to observe TAP-independent presentation (Gromme et al., 1999) . This may also explain the induction of CD8 + T cells by L d and not by HLA-A2, since expression of L d on T2-L d cells is at least 10-fold higher compared to HLA-A2 (data not shown).
Most often (non-infectious) viral proteins are fed into the endolysosome by exocytosis. However, in the case of parainfluenza virus type 1 (PIV-1 ; Sendai virus) (Zhou et al., 1993) , canine distemper virus (this study), MV fusion protein (Gromme et al., 1999) and N protein (this study) infection and therefore protein synthesis in the cytoplasm led to recognition in a TAP-independent and chloroquine-sensitive manner. In contrast to a recombinant vaccinia virus, MV and CDV are able to present the N protein as well as β-galactosidase protein in a TAP-independent manner. During MV infection, the ribonucleoprotein (RNP) complex containing the viral RNA, polymerase, phosphoprotein (P) and N protein forms and is translocated to the cell surface where it is enveloped into a budding virus. It has been shown that MV-N (Narang, 1973) , MV-P and the matrix (M) protein (which links the RNP complex to the envelope) (Cathomen et al., 1998) accumulate intracellularly in small aggregates. Some of these aggregates containing MV-M and MV-N colocalize with LAMP-1 in the endolysosomal compartment (this study). The expression of MV-N alone did not reveal targeting into the endolysosomal compartment. It therefore is likely that the transport of MV-N into this localization is only possible in the context of the RNP complex or as part of an aberrant intracellular budding process. PIV-1, CDV and MV belong to the Paramyxoviridae family, share the same mode of replication and budding and are recognized in a TAP-independent fashion. It is interesting to note that a completely unrelated protein like β-galactosidase can be presented in a TAP-independent manner only after expression by a recombinant MV. The intracellular assembly of MV-RNP and the multiple interactions of the viral proteins with cellular motor proteins could influence the uptake of β-galactosidase to the lysosome by a yet undefined mechanism. To fully understand the underlying mechanism, a precise knowledge of the stepwise assembly of paramyxoviruses in intracellular compartments is worth determining.
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